News | November 20, 2006

First DeBakey Award Goes to ThromboVision

Houston based ThromboVision, Inc. has won the first annual Michael E. DeBakey Life Science Award, which carries a $50,000 cash prize to assist in propelling the company's technology toward commercial success.

ThromboVision's initial product, currently in late-stage development, is a platelet function monitor called the ThromboGuide (T-Guide). This device will help physicians individualize antiplatelet therapy when they treat cardiovascular patients for heart attacks, strokes and stent occlusions.

The award was presented to ThromboVision's president and CEO, Edward R. Teitel, M.D., JD, MBA, by Dr. DeBakey; Malcolm Gillis, PhD, BioHouston chairman; and John Mendelsohn, M.D., president, The University of Texas M.D. Anderson Cancer Center, at BioHouston's 2006 Texas Life Science Conference.

"We're in this business to save lives," said Dr. Teitel. "The sooner we can submit our system to the FDA for approval to market, the sooner we can help physicians improve their patients' care. We expect that access to the HTC's high-level planning expertise and potential funding sources will accelerate our growth model."

For more information visit

Related Content

clinical trial study antiplatelet thomas jefferson cath function monitors
News | December 12, 2013
Thomas Jefferson University researchers discovered that the formation of blood clots follows a different molecular...
antiplatelet therapy clinical trial blood test platelet function corgenix
News | November 15, 2013
study conducted in Ireland found that...
Feature | November 14, 2013
Professional cardiovascular societies and many working cardiologists question the U.S. Food and Drug Administration’s (...
News | September 23, 2013
Aggredyne Inc., has received ISO 13485 certification for its quality control program related to the manufacture of the...
News | September 05, 2013
September 5, 2013 — ITC Nexus Holding Co., a company in hemostasis management and point-of-care (POC) testing,...
News | July 22, 2013
T2 Biosystems announced the presentation of data strongly correlating T2Hemostat results with patients’ clinical...
Clinical Study Aspirin Duke Medicine Blood Test Platelet Functioning Testing
News | July 12, 2013
Aspirin has been widely used for more than 50 years as a common, inexpensive blood thinner for patients with heart...
cath lab, SYNTAX, SCAI
Feature | July 03, 2013 | Dmitriy N. Feldman, M.D., FACC, FSCAI
The year 2013 has brought us several important clinical trials that have changed the way interventional cardiologists...
UK Blood Clots Teststing Wafarin Self Monitoring
News | April 29, 2013
A simple self-monitoring test could reduce the risk of stroke by half in thousands of people in the United Kingdom who...
Overlay Init